SEC Form 4 · accession 0000899243-19-004401
Molecular Templates, Inc. · MTEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger J. Waltzman
Officer — SVP, Chief Medical Officer
Period of report
Feb 19, 2019
Accepted (ET)
Feb 21, 2019 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001183765
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.80 | Feb 19, 2019 | A | 175,000 | A | — | Feb 19, 2029 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F125% of the shares subject to the option shall vest on February 19, 2020, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months.